Company Filing History:
4 out of 10 
1 out of 14 
1 out of 75 
Years Active: 2009-2019
Title: Edzard Spillner: Innovator in Complement Modulation
Introduction
Edzard Spillner is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of complement modulation. With a total of 4 patents to his name, Spillner's work has the potential to impact therapeutic strategies in vaccination and immune response.
Latest Patents
Spillner's latest patents include innovative approaches to complement activation and depletion. One of his key inventions is a pharmaceutical composition that utilizes controlled activation of complement components as an endogenous adjuvant. This invention involves a formulation comprising a therapeutically effective dose of at least one recombinant human C3-derivative and at least one antigen for vaccination. Another significant patent focuses on complement depletion using recombinant human C3 derivatives. This invention provides isolated polypeptides with complement-modulating activity, specifically designed to efficiently consume complement in human serum, thereby enhancing therapeutic efficacy.
Career Highlights
Throughout his career, Edzard Spillner has worked with various organizations that have allowed him to advance his research and innovations. Notably, he has been associated with Pls-design GmbH and Klinikum Rechts Der Isar Der Technischen Universität München. His work in these institutions has contributed to the development of novel therapeutic strategies.
Collaborations
Spillner has collaborated with esteemed colleagues such as Reinhard Bredehorst and Johanna Kölln. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field.
Conclusion
Edzard Spillner's contributions to the field of complement modulation through his patents and collaborations highlight his role as a significant innovator. His work continues to pave the way for advancements in therapeutic applications, particularly in vaccination and immune response enhancement.